Malignant Pain
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain (NCT02321397) | Mundipharma Research GmbH & Co KG | 2014-11-01 |
Track Malignant Pain automatically
Every clearance here is in the API, with alerts when new ones post.